Drug Pipeline

GR1803 injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07452198 A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in… Multiple Myeloma Recruiting
Phase 2
NCT06566547 GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma Active, Not Recruiting
Phase 1/2
NCT07348055 A Study of GR1803 in Systemic Lupus Erythematosus Systemic Lupus Erthematosus Recruiting
Sponsors Running GR1803 injection Trials
Genrix (Shanghai) Biopharmaceutical Co., Ltd. (3)
Disease Areas
Multiple Myeloma (2) Lupus (SLE) (1)
Get alerts when GR1803 injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free